Rogue proliferation versus restorative protection: Where do we draw the line for Wnt and Forkhead signaling?
Authors:
- 13 June 2008
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 12 (7) , 905-916
Abstract
(2008). Rogue proliferation versus restorative protection: Where do we draw the line for Wnt and Forkhead signaling? Expert Opinion on Therapeutic Targets: Vol. 12, No. 7, pp. 905-916.Keywords
This publication has 101 references indexed in Scilit:
- Wnt-pathway activation during the early stage of neurodegeneration in FTDP-17 miceNeurobiology of Aging, 2009
- OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteinsTrends in Molecular Medicine, 2008
- The Wnt signaling pathway: Aging gracefully as a protectionist?Pharmacology & Therapeutics, 2008
- Raves and risks for erythropoietinCytokine & Growth Factor Reviews, 2008
- FoxO tumor suppressors and BCR–ABL-induced leukemia: A matter of evasion of apoptosisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2007
- Wnts: up-and-coming at the synapseTrends in Neurosciences, 2007
- Cellular demise and inflammatory microglial activation during β-amyloid toxicity are governed by Wnt1 and canonical signaling pathwaysCellular Signalling, 2007
- Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3β/caspase-3 mediated signaling pathwayApoptosis, 2007
- FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell HomeostasisCell, 2007
- New Avenues of Exploration for ErythropoietinJAMA, 2005